Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas

To evaluate, through a systematic review of the literature, the antitumoral effects of cannabinoids on gliomas. Research included the following electronic databases: PUBMED, EMBASE, LILACS

September 19, 2019

Systematic review of the impact of cannabinoids on neurobehavioral outcomes in preclinical models of traumatic and nontraumatic spinal cord injury

Abstract Study design Systematic review. Objectives To evaluate the impact of cannabinoids on neurobehavioral outcomes in preclinical models of nontraumatic and traumatic spinal cord injury

April 1, 2024

Systematic review of systematic reviews for medical cannabinoids

Abstract Objective To determine the effects of medical cannabinoids on pain, spasticity, and nausea and vomiting, and to identify adverse events. Data sources MEDLINE, the Cochrane Database,

November 4, 2024

Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants

Abstract Cannabis use peaks in adolescence, and adolescents may be more vulnerable to the neural effects of cannabis and cannabis-related harms due to ongoing brain

February 29, 2024

Systematic Review and Meta-Analysis: Medical and Recreational Cannabis Legalization and Cannabis Use Among Youth in the United States

Please use this link to access this publication. Abstract Objective Dramatic changes in state-level cannabis laws (CL) over the past 25 years have shifted societal

February 27, 2025

Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain

Abstract We report a systematic review and meta-analysis of studies that assessed the antinociceptive efficacy of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators on pain-associated

March 29, 2024

Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures

Abstract There can be a fine line between therapeutic intervention and substance abuse, and this point is clearly exemplified in herbal cannabis and its products.

August 1, 2024

Synthetic cannabinoids: far from being a “soft drug”

Please use this link to access this publication. Abstract in English, French Cannabis is one of the world’s most widely consumed illicit substances. In addition to being

April 18, 2026

Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation

August 30, 2025

Synthetic cannabinoids and their impact on neurodevelopmental processes

Please use this link to access this publication. Abstract Cannabinoids comprise a broad group of psychoactive substances that activate endogenous cannabinoid (EC) receptors (ie, CB1R

September 13, 2025